Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Oct 9;9(79):35008-35025.
doi: 10.18632/oncotarget.26150.

Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity

Affiliations
Review

Effect of therapies-mediated modulation of telomere and/or telomerase on cancer cells radiosensitivity

Ganiou Assani et al. Oncotarget. .

Abstract

Cancer is one of the leading causes of death in the world. Many strategies of cancer treatment such as radiotherapy which plays a key role in cancer treatment are developed and used nowadays. However, the side effects post-cancer radiotherapy and cancer radioresistance are two major causes of the limitation of cancer radiotherapy effectiveness in the cancer patients. Moreover, reduction of the limitation of cancer radiotherapy effectiveness by reducing the side effects post-cancer radiotherapy and cancer radioresistance is the aim of several radiotherapy-oncologic teams. Otherwise, Telomere and telomerase are two cells components which play an important role in cancer initiation, cancer progression and cancer therapy resistance such as radiotherapy resistance. For resolving the problems of the limitation of cancer radiotherapy effectiveness especially the cancer radio-resistance problems, the radio-gene-therapy strategy which is the use of gene-therapy via modulation of gene expression combined with radiotherapy was developed and used as a new strategy to treat the patients with cancer. In this review, we summarized the information concerning the implication of telomere and telomerase modulation in cancer radiosensitivity.

Keywords: cancer cells; radiosensitivity; radiotherapy; telomerase; telomere.

PubMed Disclaimer

Conflict of interest statement

CONFLICTS OF INTEREST No competing interests regarding this review.

Figures

Figure 1
Figure 1. Schema of telomere structure with shelterin complex (Telosome) and T-loop formation
Figure 2
Figure 2. Schematic diagram of link between therapies associated with telomere or telomerase modulation and Cancer Radiosensitivity

Similar articles

Cited by

References

    1. Wang H, Naghavi M, Allen C, Barber RM, Bhutta ZA, Carter A, Casey DC, Charlson FJ, Chen AZ, Coates MM, Coggeshall M, Dandona L, Dicker DJ, et al. GBD 2015 Mortality and Causes of Death Collaborators. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1459–544. - PMC - PubMed
    1. Clifton K, Gutierrez-Barrera A, Ma J, Bassett R, Jr, Litton J, Kuerer H, Moulder S, Albarracin C, Hortobagyi G, Arun B. Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations. Breast Cancer Res Treat. 2018;170:101–09. - PMC - PubMed
    1. Ochoa CE, Joseph RW. Nivolumab in Renal Cell Carcinoma: Current Trends and Future Perspectives. J Kidney Cancer VHL. 2018;5:15–18. - PMC - PubMed
    1. Liu F, Xu K, Yang H, Li Y, Liu J, Wang J, Guan Z. A novel approach to glioma therapy using an oncolytic adenovirus with two specific promoters. Oncol Lett. 2018;15:3362–68. - PMC - PubMed
    1. Sakurai Y, Kajimoto K, Harashima H. Anti-angiogenic nanotherapy via active targeting systems to tumors and adipose tissue vasculature. Biomater Sci. 2015;3:1253–65. - PubMed